Evidence map›Paper›PMID 33506010›Full record

ArticleBioMed research international2021

Protective Effect of Zuojin Fang on Lung Injury Induced by Sepsis through Downregulating the JAK1/STAT3 Signaling Pathway.

Jiangning Yin, Zhan Yu, Chuanyong Hou, Yigen Peng, Jianpeng Xiao, Jun Jiang

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jiangning YinEmergency Department, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu 211100, China.ORCID https://orcid.org/0000-0003-0258-572X
Zhan YuEmergency Department, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu 211100, China.
Chuanyong HouEmergency Department, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu 211100, China.
Yigen PengEmergency Department, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu 211100, China.
Jianpeng XiaoSchool of Pharmacy, Jiangsu University, Xuefu Road, Zhenjiang, Jiangsu 212013, China.
Jun JiangSchool of Pharmacy, Jiangsu University, Xuefu Road, Zhenjiang, Jiangsu 212013, China.ORCID https://orcid.org/0000-0002-6342-165X
Jiangsu University · CNNanjing Jiangning Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung injury was the common and serious complication of sepsis, a systemic inflammatory response syndrome caused by severe infections. Chinese medicine had unique advantages in attenuating inflammatory response, such as Zuojinfang (ZJF). ZJF was a classical compound herb formula composed of Coptidis Rhizoma and Euodiae Fructus in a ratio of 6 : 1. In this paper, 15 ingredients in ZJF were identified and 8 of them absorbed into rat's serum were quantified by HPLC-MS/MS. Subsequently, sepsis-induced lung injury model was replicated in rats by cecal ligation and puncture. 60 SD rats were randomly divided into 6 groups (

Indexed as

Acute Lung InjuryAnimalsDisease Models, AnimalDown-RegulationDrugs, Chinese HerbalJanus Kinase 1MaleProtective AgentsRatsRats, Sprague-DawleySepsisSignal TransductionSTAT3 Transcription FactorDrugs, Chinese HerbalJak1 protein, ratJanus Kinase 1Protective AgentsStat3 protein, ratSTAT3 Transcription Factorzuojin

Identifiers

PMID33506010
PMCPMC7808815
OpenAlexW3119655623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.